Jocelin Huang

Risk factors for leukemic transformation in patients with primary myelofibrosis

Jocelin Huang, Chin‐Yang Li, Ruben A. Mesa et al. · Cancer · 2008 · 125 citations · Full text

Validation and comparison of contemporary prognostic models in primary myelofibrosis

Ayalew Tefferi, Jocelin Huang, Susan M. Schwager et al. · Cancer · 2007 · 66 citations

Karyotype complements the International Prognostic Scoring System for primary myelofibrosis

Kebede Hussein, Jocelin Huang, Terra L. Lasho et al. · European Journal Of Haematology · 2009 · 51 citations

Immunohematology, Mixed-phenotype Acute Leukemia, Immunodeficiencies +18

Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147

Jocelin Huang, Suresh Nair, Michelle R. Mahoney et al. · Clinical Colorectal Cancer · 2014 · 44 citations · Full text

Intergroup Trial N0147, Surgical Oncology, Gastrointestinal Oncology +9

Mature Survival Data for 176 Patients Younger Than 60 Years With Primary Myelofibrosis Diagnosed Between 1976 and 2005: Evidence for Survival Gains in Recent Years

Rakhee Vaidya, Sergio Siragusa, Jocelin Huang et al. · Mayo Clinic Proceedings · 2009 · 20 citations · Full text

Hematological Malignancy, Prognostic Evaluation, Disease Progression +10